News
Seattle Genetics changes its name to Seagen Inc.
Seagen Inc. is the new corporate name for Seattle Genetics, Inc., a global biotechnology company dedicated to developing innovative cancer medicines that make a meaningful difference in people’s lives around the world.
The evolution of the corporate name reflects the transformation of Seagen as it expands operations globally to bring its marketed medicines to more patients, pursues new indications for approved medicines and continues to advance its pipeline of novel therapies for solid tumors and blood-related cancers. The Company’s common stock will continue to trade under its current ticker symbol: “SGEN.”
Type: industry